The Lead Discovery Center receives one million euros from the Max Planck Foundation for the development of new drug candidates.
The Max Planck Institute of Biochemistry (MPIB), the Lead Discovery Center GmbH (LDC) and Qurient Co., Ltd have entered into a license agreement providing Qurient with world-wide
Page 1 of 1